Skip to main content
Theralase Technologies Inc. (TSXV:TLT)
Canada flag Canada · Delayed Price · Currency is CAD
0.265
-0.005 (-1.85%)
At close: Mar 9, 2026

Theralase Technologies Revenue

Theralase Technologies had revenue of 279.64K CAD in the quarter ending September 30, 2025, a decrease of -19.32%. This brings the company's revenue in the last twelve months to 1.00M, up 1.46% year-over-year. In the year 2024, Theralase Technologies had annual revenue of 1.03M, down -3.45%.

Revenue (ttm)
1.00M
Revenue Growth
+1.46%
P/S Ratio
71.48
Revenue / Employee
50.05K
Employees
20
Market Cap
71.55M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20241.03M-36.88K-3.45%
Dec 31, 20231.07M-68.26K-6.00%
Dec 31, 20221.14M357.93K45.85%
Dec 31, 2021780.64K-148.48K-15.98%
Dec 31, 2020929.12K-34.93K-3.62%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Perimeter Medical Imaging AI 2.78M
Conavi Medical 706.00K
Cheelcare 1.56M
Ventripoint Diagnostics 175.62K
Aurora Spine 25.14M
Profound Medical 22.07M
MedX Health 522.90K
VVT Med 156.00K
Revenue Rankings

Theralase Technologies News

More News